Pierre-Olivier Fernagut
Affiliations: | Institute of Neurodegenerative Diseases | Université de Bordeaux, Talence, Nouvelle-Aquitaine, France |
Google:
"Pierre-Olivier Fernagut"Mean distance: 17.56
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sikora J, Dovero S, Kinet R, et al. (2024) Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primates. Npj Parkinson's Disease. 10: 141 |
| Lopez-Cuina M, Guérin P, Dutheil N, et al. (2023) GRK2-Targeted Knockdown as Therapy for Multiple System Atrophy. Movement Disorders : Official Journal of the Movement Disorder Society |
| Decourt M, Balado E, Francheteau M, et al. (2023) Premorbid performances determine the deleterious effects of nigrostriatal degeneration and pramipexole on behavioural flexibility. Npj Parkinson's Disease. 9: 31 |
| Mallet D, Dufourd T, Decourt M, et al. (2021) A metabolic biomarker for early stage of Parkinson's disease in patients and animal models. The Journal of Clinical Investigation |
| Theis H, Probst C, Fernagut PO, et al. (2021) Unlucky punches: the vulnerability-stress model for the development of impulse control disorders in Parkinson's disease. Npj Parkinson's Disease. 7: 112 |
| Bassil F, Delamarre A, Canron MH, et al. (2021) Impaired brain insulin signalling in Parkinson's disease. Neuropathology and Applied Neurobiology |
| Decourt M, Jiménez-Urbieta H, Benoit-Marand M, et al. (2021) Neuropsychiatric and Cognitive Deficits in Parkinson's Disease and Their Modeling in Rodents. Biomedicines. 9 |
| Sun X, Yu X, Zhang L, et al. (2021) Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE. Heliyon. 7: e06302 |
| Fridjonsdottir E, Shariatgorji R, Nilsson A, et al. (2021) Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia. Science Advances. 7 |
| Deffains M, Canron MH, Teil M, et al. (2020) L-DOPA regulates α-synuclein accumulation in experimental parkinsonism. Neuropathology and Applied Neurobiology |